Addition of docetaxel to S-1 results in significantly superior 5-year survival outcomes in Stage III gastric cancer: a final report of the JACCRO GC-07 study (vol 26, 1063, 2023)

被引：0
|
作者：
Kodera, Yasuhiro [1 ]
Yoshida, Kazuhiro [2 ]
Kochi, Mitsugu [3 ]
Sano, Takeshi [4 ]
Ichikawa, Wataru [5 ]
Kakeji, Yoshihiro [6 ]
Sunakawa, Yu [7 ]
Takeuchi, Masahiro [8 ]
Fujii, Masashi [9 ]
机构：
[1] Nagoya Univ, Dept Surg Gastroenterol, Grad Sch Med, 65 Tsurumai Cho,Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Gifu Univ, Dept Surg Oncol, Gifu, Japan
[3] Int Univ Hlth & Welf, Sch Med, Dept Hepatobiliary Pancreat & Gastrointestinal Su, Ichikawa, Japan
[4] Canc Inst Hosp, Gastroenterol Surg, Tokyo, Japan
[5] Showa Univ, Div Med Oncol, Fujigaoka Hosp, Yokohama, Kanagawa, Japan
[6] Kobe Univ, Div Gastrointestinal Surg, Dept Surg, Grad Sch Med, Kobe, Hyogo, Japan
[7] St Marianna Univ, Dept Clin Oncol, Sch Med, Kawasaki, Kanagawa, Japan
[8] Univ Tokyo, Grad Sch Math Sci, Tokyo, Japan
[9] Nihon Univ, Dept Digest Surg, Sch Med, Tokyo, Japan
来源：
GASTRIC CANCER | 2024年 / 27卷 / 05期
关键词：
D O I：
10.1007/s10120-024-01519-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1157 / 1157
页数：1
相关论文
共 19 条
  • [11] Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy
    Kazumasa Fujitani
    Shigeyuki Tamura
    Yutaka Kimura
    Takeshi Tsuji
    Jin Matsuyama
    Shohei Iijima
    Hiroshi Imamura
    Kentaro Inoue
    Kenji Kobayashi
    Yukinori Kurokawa
    Toshio Shimokawa
    Toshimasa Tsujinaka
    Hiroshi Furukawa
    Gastric Cancer, 2014, 17 : 348 - 353
  • [12] Five-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy (OGSG1002)
    Kazumasa Fujitani
    Shigeyuki Tamura
    Yutaka Kimura
    Jin Matsuyama
    Hiroshi Imamura
    Kazuyoshi Yamamoto
    Junya Fujita
    Shohei Iijima
    Shugo Ueda
    Yukinori Kurokawa
    Toshio Shimokawa
    Taroh Satoh
    Gastric Cancer, 2020, 23 : 520 - 530
  • [13] Five-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy (OGSG1002)
    Fujitani, Kazumasa
    Tamura, Shigeyuki
    Kimura, Yutaka
    Matsuyama, Jin
    Imamura, Hiroshi
    Yamamoto, Kazuyoshi
    Fujita, Junya
    Iijima, Shohei
    Ueda, Shugo
    Kurokawa, Yukinori
    Shimokawa, Toshio
    Satoh, Taroh
    GASTRIC CANCER, 2020, 23 (03) : 520 - 530
  • [14] Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy (OGSG1002)
    Ryohei, Kawabata
    Kazumasa, Fujitani
    Shigeyuki, Tamura
    Yutaka, Kimura
    Hiroshi, Imamura
    Junya, Fujita
    Jin, Matsuyama
    Shohei, Iijima
    Shugo, Ueda
    Yukinori, Kurokawa
    Daisuke, Sakai
    Toshio, Shimokawa
    Toshimasa, Tsujinaka
    Hiroshi, Furukawa
    Taroh, Satoh
    ANNALS OF ONCOLOGY, 2017, 28
  • [15] FIVE-YEAR RESULTS OF THE RANDOMIZED PHASE III TRIAL COMPARING S-1 MONOTHERAPY VERSUS SURGERY ALONE FOR STAGE II/III GASTRIC CANCER PATIENTS AFTER CURATIVE D2 GASTRECTOMY (ACTS-GC STUDY)
    Sasako, M.
    Kinoshita, T.
    Furukawa, H.
    Yamaguchi, T.
    Nashimoto, A.
    Fujii, M.
    Nakajima, T.
    Ohashi, Y.
    ANNALS OF ONCOLOGY, 2010, 21 : 225 - 225
  • [16] 5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer
    Takaki Yoshikawa
    Masanori Terashima
    Junki Mizusawa
    Souya Nunobe
    Yasunori Nishida
    Takanobu Yamada
    Masahide Kaji
    Takashi Nomura
    Shinji Hato
    Yasuhiro Choda
    Hiroshi Yabusaki
    Kazuhiro Yoshida
    Kazunari Misawa
    Toru Masuzawa
    Masahiro Tsuda
    Yasuyuki Kawachi
    Hiroshi Katayama
    Haruhiko Fukuda
    Yukinori Kurokawa
    Narikazu Boku
    Takeshi Sano
    Mitsuru Sasako
    Gastric Cancer, 2024, 27 : 155 - 163
  • [17] 5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer
    Yoshikawa, Takaki
    Terashima, Masanori
    Mizusawa, Junki
    Nunobe, Souya
    Nishida, Yasunori
    Yamada, Takanobu
    Kaji, Masahide
    Nomura, Takashi
    Hato, Shinji
    Choda, Yasuhiro
    Yabusaki, Hiroshi
    Yoshida, Kazuhiro
    Misawa, Kazunari
    Masuzawa, Toru
    Tsuda, Masahiro
    Kawachi, Yasuyuki
    Katayama, Hiroshi
    Fukuda, Haruhiko
    Kurokawa, Yukinori
    Boku, Narikazu
    Sano, Takeshi
    Sasako, Mitsuru
    GASTRIC CANCER, 2024, 27 (01) : 155 - 163
  • [18] 5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer
    Kim, Hyung-Don
    Ryu, Min-Hee
    Lee, Ji Sung
    Kang, Yoon-Koo
    GASTRIC CANCER, 2024, 27 (04) : 884 - 885
  • [19] Reply to letter to the editor: "5-year follow-up results of a JCOG1104 (OPAS-1) phase III noninferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer"
    Yoshikawa, Takaki
    Terashima, Masanori
    Mizusawa, Junki
    GASTRIC CANCER, 2024, 27 (05) : 1155 - 1156
12